US 11078486
Compounds and methods for reducing ATXN2 expression
granted A61KA61K47/02A61K47/46
Quick answer
US patent 11078486 (Compounds and methods for reducing ATXN2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K47/02, A61K47/46